Quel est le prix pour Entia Biosciences, Inc. (ERGO)

Le prix pour Entia Biosciences, Inc. (ERGO) est $0.0002

Quelle est la capitalisation boursière pour Entia Biosciences, Inc. (ERGO)

La capitalisation boursière pour Entia Biosciences, Inc. (ERGO) est $6.73K

Bénéfices de Entia Biosciences, Inc. (ERGO)

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceuticals, cosmetics, and other products. In addition, the company offers beauty products under the GROH brand name. It markets its products directly to consumers through e-commerce channels, such as direct email marketing, social media outlets, and e-commerce sites. The company was formerly known as Total Nutraceutical Solutions, Inc. and changed its name to Entia Biosciences, Inc. in January 2012. Entia Biosciences, Inc. was incorporated in 2007 and is headquartered in Sherwood, Oregon.

Année	Bénéfices	Changez
Pas assez de données pour les dates fournies.

Année

Bénéfices

Changez

Pas assez de données pour les dates fournies.

Entreprise	Bénéfices	Différence de bénéfices	Pays
Royalty Pharma plc RPRX.US	$1.35B	-	US
Swedish Orphan Biovitrum AB SOBI.ST	-	-	SE
Ipsen S.A. IPN.PA	-	-	FR
Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI	-	-	IT
Corcept Therapeutics Incorporated CORT.US	$26.37M	-	US

Entreprise

Bénéfices

Différence de bénéfices

Pays